Global Neurointerventional Devices Market

 

Neurointerventional devices are used for neurointervention procedure which is minimally invasive treatment for disorders of the blood vessels in the brain and the spine. It is minimally invasive campared to other conventional modes of treatment and offer shorter recovery time, less pain, and fewer complications after procedure is done.

 

Market Drivers

 

The rise in prevalence of brain aneurysm is the key driving factor which is expected to boost the global neurointerventional devices market growth. For instant, as per the Cerebral Aneurysms fact sheet, National Institute of Neurological Disorders and Stroke, May 2018, around 30,000 people suffering from brain aneurysm rupture, annually in U.S. Furthermore, rise in cases of Traumatic Brain injuries will positively influence the market growth. Also, increase in technological advancements in Embolic coil devices to expand revenue tool is expected to propel the global neurointerventional devices market growth. In addition to that, increase in product approval activities by regulatory authorities will fuel the market growth over the forecast period. For instance, in 2019, Shape Medical’s TrelliX Embolic Coil had received CE mark for intracranial aneurysms and other neurovascular abnormalities like arteriovenous fistulae.

 

Market Restraints

 

However, high cost of neurointerventional devices is the major challenging factor for market which is expected to hinder the global neurointerventional devices market growth. Also, recently launch devices have severely criticized for their performance which is expected to hamper the market growth.

 

Market Segmentation

 

Global Neurointerventional Devices Market is segmented into type such as Neurovascular Thrombectomy Devices, Neurovascular Stents, Embolic Coils, Intrasaccular Devices, Liquid Embolics, Flow Diverters, Balloons, Embolic Protection Devices, and Stent Retrievers, by technique such as Neurothrombectomy, Coiling Procedure,  Stenting, Cerebral Angiography, and Flow Disruption. Further, market is segmented into end user such as Hospitals, and Ambulatory Surgical Centers.

Also, Global Neurointerventional Devices Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

 

Market key Players

 

Various key players are discussed in this report such as Medtronic, Stryker Corporation, Penumbra Inc., Johnson & Johnson Private Limited, Anaconda Biomed S.L, Imperative Care Inc., Perflow Medical, Insera Therapeutics, Inc.,and Terumo Corporation.

 

Market Taxonomy

 

By Type Neurovascular Thrombectomy Devices Neurovascular Stents Embolic Coils Intrasaccular Devices Liquid Embolics Flow Diverters Balloons Embolic Protection Devices Stent Retrievers

By Technique Neurothrombectomy Coiling Procedure Stenting Cerebral Angiography Flow Disruption

By End User Hospitals Ambulatory Surgical Centers

By Region

  • North America
  • Latin America
  • Europe Asia
  • Pacific Middle
  • East & Africa

Key Questions Addressed by the Report What are the Key

  • Opportunities in Global Neurointerventional Devices Market?
  • What will be the growth rate from 2019 to 2030?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?
  • What are the strategies adopted by key players?

Global Neurointerventional Devices Market

1 Introduction   

1.1 Objective of the Study

1.2 Market definition

1.3 Market Scope

 

2 Research Methodology

2.1 Data Mining

2.2 Validation

2.3 Primary Interviews

2.4 List of Data Sources

 

3 Executive Summary

4 Global Neurointerventional Devices Market Outlook

4.1 Overview

4.2 Market Dynamics

4.2.1 Drivers

4.2.2 Restraints

4.2.3 Opportunities

4.3 Porters Five Force Model

4.4 Value Chain Analysis

 

5 Global Neurointerventional Devices Market, By Type

5.1 Y-o-Y Growth Comparison, By Type

5.2 Global Neurointerventional Devices Market Share Analysis, By Type

5.3 Global Neurointerventional Devices Market Size and Forecast, By Type

5.3.1 Neurovascular Thrombectomy Devices

5.3.2. Neurovascular Stents

5.3.3 Embolic Coils

5.3.4 Intrasaccular Devices

5.3.5 Liquid Embolics

5.3.6 Flow Diverters

5.3.7 Balloons

5.3.8 Embolic Protection Devices

5.3.9 Stent Retrievers

 

6 Global Neurointerventional Devices Market, By Technique

6.1 Y-o-Y Growth Comparison, By Technique

6.2 Global Neurointerventional Devices Market Share Analysis, By Technique

6.3 Global Neurointerventional Devices Market Size and Forecast, By Technique

6.3.1 Neurothrombectomy

6.3.2 Coiling Procedure

6.3.3 Stenting

6.3.4 Cerebral Angiography

6.3.5 Flow Disruption

 

7 Global Neurointerventional Devices Market, By End User

7.1 Y-o-Y Growth Comparison, By End User

7.2 Global Neurointerventional Devices Market Share Analysis, By End User

7.3 Global Neurointerventional Devices Market Size and Forecast, By End User

7.3. 1 Hospital

7.3.2. Ambulatory Surgical Center

 

8Global Neurointerventional Devices Market, By Region

8.1 Global Neurointerventional Devices Market Share Analysis, By Region

8.2 Global Neurointerventional Devices Market Share Analysis, By Region

8.3 Global Neurointerventional Devices Market Size and Forecast, By Region

 

9 North America Neurointerventional Devices Market Analysis and Forecast (2020-2030)

9.1 Introduction

9.2 North America Neurointerventional Devices Market Share Analysis, By Type

9.3 North America Neurointerventional Devices Market Size and Forecast, By Technique

9.4 North America Neurointerventional Devices Market Size and Forecast, By End User

9.5 North America Neurointerventional Devices Market Size and Forecast, By Country

9.5.1 U.S.

9.5.2 Canada

9.5.3 Mexico

 

10EuropeNeurointerventional Devices Market Analysis and Forecast (2020-2030)

10.1 Introduction

10.2 Europe Neurointerventional Devices Market Share Analysis, By Type

10.3 Europe Neurointerventional Devices Market Size and Forecast, By Technique

10.4 Europe Neurointerventional Devices Market Size and Forecast, By End User

10.5 Europe Neurointerventional Devices Market Size and Forecast, By Country

10.5.1 Germany

10.5.2 France

10.5.3 UK

10.54. Rest of Europe

 

11Asia Pacific Neurointerventional Devices Market Analysis and Forecast (2020-2030)

11.1 Introduction

11.2 Asia Pacific Neurointerventional Devices Market Share Analysis, By Type

11.3 Asia Pacific Neurointerventional Devices Market Size and Forecast, By Technique

11.4 Asia Pacific Neurointerventional Devices Market Size and Forecast, By End User

11.5 Asia Pacific Neurointerventional Devices Market Size and Forecast, By Country

11.5.1 China

11.5.2 Japan

11.5.3 India

11.5.4. Rest of Asia Pacific

 

12Latin America Neurointerventional Devices Market Analysis and Forecast (2020-2030)

12.1 Introduction

12.2 Latin America Neurointerventional Devices Market Share Analysis, By Type

12.3 Latin America Neurointerventional Devices Market Size and Forecast, By Technique

12.4 Latin America Neurointerventional Devices Market Size and Forecast, By End User

12.5 Latin America Neurointerventional Devices Market Size and Forecast, Country

 

13Middle East Neurointerventional Devices Market Analysis and Forecast (2020-2030)

13.1 Introduction

 13.2 Middle East Neurointerventional Devices Market Share Analysis, By Type

13.3 Middle East Neurointerventional Devices Market Size and Forecast, By Technique

13.4 Middle East Neurointerventional Devices Market Size and Forecast, By End User

13.5 Middle East Neurointerventional Devices Market Size and Forecast, By Country

 

14Competitive Analysis

14.1 Competition Dashboard

14.2 Market share Analysis of Top Vendors

14.3 Key Development Strategies

 

15Company Profiles

15.1 Medtronic

15.1.1 Overview

15.1.2 Offerings

15.1.3 Key Financials

15.1.4 Business Segment & Geographic Overview

15.1.5 Key Market Developments

15.1.6 Key Strategies

15.2. Stryker Corporation

15.2.1 Overview

15.2.2 Offerings

15.2.3 Key Financials

15.2.4 Business Segment & Geographic Overview

15.2.5 Key Market Developments

15.2.6 Key Strategies

15.3. Penumbra Inc

15.3.1 Overview

15.3.2 Offerings

15.3.3 Key Financials

15.3.4 Business Segment & Geographic Overview

15.3.5 Key Market Developments

15.3.6 Key Strategies

15.4 Johnson & Johnson Private Limited

15.4.1 Overview

15.4.2 Offerings

15.4.3 Key Financials

15.4.4 Business Segment & Geographic Overview

15.4.5 Key Market Developments

15.4.6 Key Strategies

15.5 Anaconda Biomed S.L

15.5.1 Overview

15.5.2 Offerings

15.5.3 Key Financials

15.5.4 Business Segment & Geographic Overview

15.5.5 Key Market Developments

15.5.6 Key Strategies

15.6 Imperative Care Inc

15.6.1 Overview

15.6.2 Offerings

15.6.3 Key Financials

15.6.4 Business Segment & Geographic Overview

15.6.5 Key Market Developments

15.6.6 Key Strategies

15.7 Perflow Medical

15.7.1 Overview

15.7.2 Offerings

15.7.3 Key Financials

15.7.4 Business Segment & Geographic Overview

15.7.5 Key Market Developments

15.7.6 Key Strategies        

15.8 Insera Therapeutics, Inc

15.8.1 Overview

15.8.2 Offerings

15.8.3 Key Financials

15.8.4 Business Segment & Geographic Overview

15.8.5 Key Market Developments

15.8.6 Key Strategies

15.9 Terumo Corporation

15.9.1 Overview

15.9.2 Offerings

15.9.3 Key Financials

15.9.4 Business Segment & Geographic Overview

15.9.5 Key Market Developments

15.9.6 Key Strategies